Tralokinumab associated with increased risk of conjunctivitis in severe AD: study Dr. Shravani Dali16 Nov 2021 9:00 AM ISTTreatment with tralokinumab was associated with an increased incidence of conjunctivitis, according to a recent study published in the British...
Tralokinumab, topical corticosteroids combination beneficial in Atopic dermatitis Dr. Nandita Mohan9 Nov 2021 5:41 PM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide....
Medical Bulletin 8/ November /2021 Dr. Nandita Mohan9 Nov 2021 11:53 AM ISTHere are Top Medical Stories of the dayTralokinumab, corticosteroids helpful in ADAtopic dermatitis (AD), is a common chronic or recurrent...
Tralokinumab plus topical corticosteroids effective in severe atopic dermatitis MD Editorial Team8 Nov 2021 9:00 AM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide. ...
Dupilumab use in Severe Atopic Dermatitis may induce two types of Ocular Surface Diseases Dr. Shravani Dali30 Oct 2021 9:00 AM ISTTwo types of Ocular Surface Diseases were found induced by Dupilumab in Severe Atopic Dermatitis, according to a study published in the Ophthalmology...
Topical JAK and PDE4 inhibitors promising treatments for Atopic dermatitis: Study MD Editorial Team22 Oct 2021 9:00 AM ISTChina: Topical Janus kinase (JAK) and phosphodiesterase-4 (PDE4) inhibitors are novel treatment approaches for atopic dermatitis (AD).A new study...
Pfizer Abrocitinib for atopic dermatitis approved in Japan Ruchika Sharma3 Oct 2021 9:00 AM ISTNew York: Pfizer Inc. has recently announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved...
FDA Approves ruxolitinib cream for treatment of Atopic Dermatitis Dr Kartikeya Kohli22 Sept 2021 9:30 PM ISTThe US food and drug administration has approved a topical selective Janus kinase (JAK)1/JAK2 inhibitor ruxolitinib (Opzelura) for the treatment of...
What's new in atopic dermatitis: JEADV updated guidelines Dr Manoj Kumar Nayak8 Sept 2021 10:00 AM ISTWhat's new in atopic dermatitis: JEADV updated guidelines Atopic dermatitis (AD) is a chronic inflammatory multifactorial cutaneous disorder that...
Abrocitinib proves efficacious in atopic dermatitis : JAMA study Dr Manoj Kumar Nayak2 Sept 2021 9:00 AM ISTAbrocitinib proves efficacious in atopic dermatitis finds a new study published in JAMA. Atopic dermatitis (AD) is a severely pruritic chronic,...
Difamilast ointment well tolerated in paediatric patients with atopic dermatitis, Study finds Dr. Nandita Mohan19 Aug 2021 9:00 AM ISTIn atopic dermatitis (AD), phosphodiesterase 4 (PDE4) inhibition reduces proinflammatory mediators and cytokines. Difamilast is a new selective PDE4...
Atopic Dermatitis linked to increased incidence of hypertension: Study Dr. Nandita Mohan14 Aug 2021 9:15 AM ISTAtopic dermatitis (AD), particularly moderate-to-severe disease, was associated with increased hypertension compared to healthy controls, but lower...
